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How to Assess Nanomaterial 
Toxicity? An Environmental and 
Human Health Approach
Matheus M. Roberto and Cintya A. Christofoletti
Abstract
Nanomaterials had been used because of the properties they exert in such scale 
(<100 nm), and they have been used in a wide variety of products like paints, 
electronics, fabrics, and also personal care products. Recent manuscripts available 
in the literature demonstrate the potential benefits of nanotechnology with these 
products. However, when released in the environment or when in contact with the 
human body, it is hard to track their final destination and their influence over the 
living beings. So, since nanomaterials were considered an important technology, 
a concern about its risks also started. Due to the variety of sizes, physicochemical 
properties, and uses, many researchers are aiming to assess the possible toxicity of 
this class of particles. Because of that, the chapter objective is to gather which assay, 
performed in vivo and in vitro, is the most frequently used and recommended to 
measure nanomaterial toxicity. Also, it is important to know which is the most 
suitable test to evaluate the toxicity over the environment, through direct effect 
and after biodegradation, and also related to human health. This chapter presents a 
concise review about the accepted methods to assess nanomaterial toxicity and also 
discuss about the need for regulamentation.
Keywords: toxicity assays, test organisms, in vitro models, in vivo assays, nanoscale 
assessment
1. Introduction
Emerging and promising nanotechnology represents a field of multidisciplinary 
knowledge responsible for development and application of materials, which 
measure less than 100 nm [1, 2]. The Royal Society and Royal Engineering Academy 
proposed this concept in 2004, which was associated to nanoscience as the branch 
responsible for studying the phenomenon of materials with atomic, molecular, and 
macromolecular scales, whose properties differ significantly from those with major 
scales [3, 4].
Nanoparticles can be generally described as ultrafine small material with 
1–100 nm; however, several types of systems not limited only by small particles of 
certain material are included in this definition, as nanotubes, nanospheres, and 
nanocapsules [4, 5]. The properties exhibited by nanomaterials are unique and are 
being applied in many fields, from industrial to medicine [6, 7]. According to Arora 
et al. [8], the use of nanomaterials is increasing for commercial purposes as fillers, 
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opacifiers, water filtration agents, cosmetic ingredients, semiconductors, electronic 
parts, and others. However, these same authors report that nanomaterials are 
being used in the medical area, mainly as agents for drug delivery, biosensors, and 
imaging contrast, i.e., human contact can happen both indirectly and directly, also 
being administered by ingestion or injection [8]. Once nanomaterials are used, 
environmental releasing turns dependent on the incorporation form of this product 
in each matrix, intrinsic material properties and also environmental conditions [9]. 
When there is human exposure or direct intake of nanomaterials, nanoparticles’ 
physicochemical properties and its possible modifications can influence absorp-
tion, distribution, and organism metabolism. Besides the potential to accumulate 
in some organs, relevant rates of nanomaterials are excreted, being released to the 
environment [10]. About the nanomaterials presence in the environment, a detailed 
description regarding its sources and fates can be found in the review of Part [11].
Due to the new scale of some materials, new physicochemical interactions may 
occur bringing unexpected and also adverse effects because these elements gener-
ally become highly reactive [12]. Physicochemical properties observed in engi-
neered nanomaterials are attributed to small size, chemical composition (purity, 
crystallinity, electronics characteristics, etc.), structural surface (reactivity, organic 
or inorganic coating, etc.), solubility, form, and agglomeration potential [8].
In view of the properties that the nanomaterials present, studies that evaluate 
the toxicity, their behavior in different environments, and the interactions with the 
biological system are of extreme importance. According to Dusinska [6], the safety 
assessment of nanomaterials is based on principles of risk assessment of “bulk” 
chemical substances. However, it is known that the behavior of these materials, 
both in the environment and in the cells, is different from such crude samples, and 
therefore the monitoring needs to be more specific. Catalán et al. [13] emphasize 
that the damaging potential of biodurable nanomaterials is not well demonstrated, 
and thus the classical toxicity evaluation trials must undergo adaptations.
2. Brief history of nanotoxicology
According to Maynard et al. [14], until the 1990s, many studies that focused on 
environmental epidemiology indicated a relationship between exposure to aerosols 
and increased mortality and morbidity of organisms. The relationships between 
particle size, chemical nature, and toxic effects were demonstrated, with the most 
pronounced effects observed in the lungs and heart due to exposure to smaller 
particles. These same authors argue that only in this decade has there been evidence 
that environmental particles with a diameter of less than 2.5 μm could cause delete-
rious health effects due to their reduced size [14]. Now it is known that engineered 
nanoparticles can perform these same activities [12].
Since the inception of this science, the studies and applications of nanoparticles 
have grown exponentially and, to the same extent, heightened concerns about 
environmental and health implications. In this context, the term nanotoxicology 
was formalized by a proposal of Donaldson et al. in 2004 [15] in an editorial in the 
journal Occupational and Environmental Medicine [5] and, since then, has been used 
to describe specifically the harmful effects of nanomaterials on environmental, 
animal, and human health. In 2005, nanotoxicology was consolidated as an area 
of expertise, with the launch of the journal Nanotoxicology, with the first article 
published by Oberdörster et al. in 2007 [16]. This article discusses the history of 
nanotoxicology as a science and presents some challenges to be faced by researchers.
Considering that nanoparticles have a greater potential to travel through the 
body than conventional-sized materials, researchers warn of the possibility of 
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numerous interactions with biological fluids, cells, and tissues. Therefore, in vitro 
tests are recommended for an initial evaluation of the cytotoxicity and genotoxic-
ity of nanomaterials, as well as for the identification and understanding of cellular 
mechanisms of toxicity [3]. In vivo methods are also used and, for both, some meth-
ods have already been developed by the Organization for Economic Co-operation 
and Development (OECD) and can be used for regulatory purposes.
3. Toxicological aspects of nanomaterials
According to Paschoalino et al. [3], the growing investment in nanoscience 
boosted the world market, as well as increased the use and consumption of prod-
ucts and processes aimed at this area. Despite this, it is true that research aimed at 
evaluating the toxicity of nanomaterials is still necessary, since the same properties 
that make nanomaterials so attractive may also be responsible for harmful effects on 
living organisms.
In this context, there is a recommendation for the analysis of physicochemi-
cal properties of nanomaterials in relation to human health and environmental 
safety (Table 1). In 2006, the OECD established a working party on manufactured 
nanomaterials to determine the appropriate methods for evaluating nanomateri-
als. According to the guidance manual developed, 26 physicochemical properties 
should be considered [6]. However, according to these same authors, only a few 
Property Relevance
Particle size distribution Essential
Degree/state of agglomeration Important
Particle shape Important
Chemical composition/purity Essential
Solubility Essential (if 
applicable)
Physical properties
Density Matrix dependent
Crystallinity Matrix dependent
Microstructure Matrix dependent
Optical and electronic properties Matrix dependent
Bulk powder properties (important for dosimetry/exposure) Matrix dependent
Concentration (can be measured as mass, surface area, or number concentrations) Essential
Surface properties
Specific surface area/porosity Essential
Surface chemistry/reactivity Essential
Surface adsorbed species Important
Surface charge/Zeta potential (especially in aqueous biological environment— may 
change according the environment)
Important
Surface hydrophobicity Essential
Adapted from Powers et al. [17]
Table 1. 
Properties used for nanomaterial characterization regarding toxicity evaluation.
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methods are available for the characterization of the toxicological properties of the 
nanomaterials, and the association of the effects with the physicochemical charac-
terization is still a challenge.
Nanomaterials encompass a broad spectrum of materials with different physical, 
chemical, and biological properties. Thus, they do not constitute a homogeneous 
group and are usually defined by the type of core, which may be organic, such as 
fullerenes (carbon derivatives) and carbon nanotubes (single and/or multilayer), or 
inorganic, such as those of metal oxides (iron, zinc, titanium, etc.), metals (mainly 
gold and silver), and quantum dots [4].
According to Ju-Nam and Lead [4], some nanomaterials can have their surfaces 
manipulated in order to introduce specific functionalities for new applications. 
Thus, a vast field of possibilities opens up for materials with different properties 
and, therefore, also for infinite interactions with organisms and environment. 
However, the major challenge of nanotoxicology is to understand and prevent the 
risk of the use and/or exposure to nanomaterials that can cause toxicity by mecha-
nisms not yet known or not yet explained by traditional toxicology [5].
Concern about the toxicity of nanomaterials lies primarily in production and 
commercialization on such a large scale as at present. Thus, the risk of these com-
pounds reaching the different environmental compartments (atmosphere, water, 
and soil), becoming bioavailable, is very large [3, 17].
Since 2005, the European Commission Scientific Committee on Emerging and 
Newly Identified Health Risks (SCENIHR) has published reports on the impacts of 
nanoparticles on human health. The aforementioned committee focused its efforts 
on the evaluation of nanoparticles physically capable of entering the human body 
via inhalation, ingestion, and dermal absorption and reported that the size, shape, 
surface area, and chemical composition of the nanoparticle are closely associ-
ated with its toxicity. In addition, it has been explored how these characteristics 
affect bioavailability and interactions, as well as influence on exposure and dose. 
Therefore, the dose, the physicochemical properties, and the biokinetics are also 
important parameters to be evaluated when considering the toxicology of nanoma-
terials [14].
4.  Deposition and interactions of nanomaterials with cells and the 
environment
In view of the numerous properties and characteristics of nanomaterials, prod-
ucts that are increasingly light, resistant, and often of lower cost are daily produced 
and marketed by the most different segments, such as electronic, medical, pharma-
ceutical, cosmetic, food, and agricultural [3]. In this context, when considering the 
ecotoxicology of particles whose components are nontoxic in the micro- or macro-
metric scales, studies that elucidate the routes of exposure and effects of nanomate-
rials on environmental compartments and different organisms are fundamental.
According to Laux et al. [7], the entry of nanomaterials into the environment 
occurs by the release of their components during use and by final disposal, so it is 
important to track and understand the kinetics and transformation of these materi-
als in organisms and the environment. Knowledge of the influence of biopersistence 
on biokinetics and environmental fate is of utmost importance when determining 
the toxic potential.
When a nanomaterial comes in contact with the human body or the environ-
ment, it is difficult to track it again. In the environment, some nanomaterials such 
as metallic (e.g., Ag and Cu) and metal oxides (e.g., ZnO and Fe2O3) can dissolve 
rapidly, while others are more persistent (e.g., TiO2, SiO2, carbon nanotubes, and 
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graphene) [18]. However, according to these authors, soluble nanomaterials present 
the best scenario of toxicity evaluation, since their behavior is generally similar to 
that presented by their ions. However, when cells internalize them, they can solubi-
lize and release toxic metals through a mechanism known as “Trojan Horse” [18].
The aquatic ecosystem is the main route of exposure to a nanomaterial, since this 
type of environment is usually the final destination of nanocomposites introduced 
in natural systems [19]. After the aquatic environment, the atmosphere (tropo-
sphere), soil, and sediment follow an order of priority as routes of exposure. When 
present in aquatic environments, nanomaterials can be absorbed by cells, especially 
during filtration by aquatic organisms, directly interfering with their physiology 
and/or their ability to feed and breathe [3]. According to these same authors, other 
pathways of entry of nanomaterials into receptor organisms occur through cellular 
uptake, inhalation, or ingestion (Figure 1).
According to Bhaskar et al. [20] and Dusinska et al. [6], nanomaterials can enter 
the cells actively or passively, overcoming any protective barrier of the organ-
ism, including the blood-brain barrier. The capture mechanisms are related to the 
intrinsic physicochemical characteristics of the nanomaterial, as well as its route 
of exposure. Considering human health, generally the main route of exposure is 
inhalation, in which smaller particles reaching the alveoli and depending on their 
physicochemical properties cross the blood-air barrier of the lungs and reach the 
liver, heart, spleen, and kidneys [7]. There is a challenge when it comes to nanopar-
ticles developed to cross human body barriers, such as those applied in medicine. 
There are materials that are developed to pass through barriers, not to enter cells, 
while there are others that are designed to act within them [10].
The first contact of the cell with any extracellular material occurs through the 
lipid (e.g., phospholipid) and protein components (e.g., membrane receptors) 
present in the cell membrane. For Paschoalino et al. [3], the nanomaterials present 
greater permeability to the skin, mucous membranes, and cell membranes due to 
their diminutive size.
Figure 1. 
Main sources, routes of exposure, and possible interactions between nanoparticles with the environment and 
organisms (adapted from Paschoalino et al. [3]).
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Conner and Schmid [21] stated that most nanomaterials are actively incorpo-
rated by cells through endocytosis. This is one of the most important mechanisms 
of cellular communication with the external environment, since it involves the 
transmembrane and bidirectional flow of vesicles, through the movement of extra-
cellular content internalization [1]. According to Radaic et al. [1], the shape, size, 
characteristics (such as porosity) of the surface, surface charge, and composition 
of nanoparticles directly influence endocytosis. According to Drasler et al. [22], cell 
size, proliferation rate, and surface receptor growth and expression characteristics 
are the major factors involved in the entry of nanomaterials into cells. Generally, 
endocytic pathways are essential in this process, where large particles or agglomer-
ates of nanomaterials are obtained by phagocytosis (diameter greater than 250 nm), 
whereas smaller particles (diameter smaller than 150 nm) are obtained by pinocy-
tosis, specific or not. Valsami-Jones and Lynch [18] have beautifully illustrated the 
possible mechanisms of nanomaterial uptake by cells.
Collins et al. [23] have described that besides penetrating cells, many nano-
materials are able to cross nuclear membranes and gain access to chromatin at any 
stage of the cell cycle. Thus, in addition to direct damage to DNA, nanoparticles can 
induce the formation of reactive oxygen species (ROS), such as hydroxyl radicals 
(˙OH), causing oxidative stress (redox imbalance) and serious damage to the cell. 
Oxidative stress can be the result of the simple cellular response to the presence of 
the nanomaterial or a secondary effect of the inflammation generated by them [23]. 
It is also known that the dissolution of certain nanomaterials may be able to release 
toxic ions and/or other components, which may induce toxicity [22].
ROS are highly reactive molecules that disrupt intracellular medium homeosta-
sis, since they interact with cellular macromolecules such as DNA, proteins, and 
lipids [24]. Singh et al. [24], Louro et al. [25], and Radaic et al. [1] stated that nano-
materials can induce genotoxic damage mediated by oxidative stress and through 
their interaction with cellular constituents, including mitochondria and NADPH 
oxidases bound to the cell membrane; by the depletion of antioxidants; or by the 
release of the metallic ions present in the constitution of many nanomaterials, 
which can promote the conversion of cellular oxygen metabolites into ROS. When 
considering the DNA molecule, the major damage induced by ROS is single-strand 
breaks, double-strand breaks, base modifications (such as the formation of 
8-hydroxydeoxyguanosine adducts), and DNA cross-links. According to Singh et al. 
[24], all of the aforementioned damages have the potential to initiate and promote 
carcinogenesis. Once the DNA molecule has been damaged, several cellular pro-
cesses can be triggered, such as cell cycle arrest, apoptosis, or DNA repair [24].
Apart from the oxidative stress-related lesions, other genotoxic effects may 
contribute significantly to the promotion of genetic instability, as nanomaterials 
can cross the pores of the nuclear envelope and interact directly with the genome 
of the cell and/or with nuclear proteins [25]. Under these conditions, Louro et al. 
[25] reported that some nanomaterials induce the formation of intranuclear protein 
aggregates, inhibiting the processes of cell replication, transcription, and prolifera-
tion. When the nanomaterials are not able to cross the nuclear envelope, there is still 
the possibility of interaction with the DNA molecule and nuclear proteins during 
the mitotic process, which can cause aneuploidies [24, 25].
Depending on the organism exposed to the nanomaterials, different interactions 
can be evidenced. Bielmeyer-Fraser et al. [26] demonstrated that nanoparticles of 
ZnO, AgO, and CuO were able to induce toxicity to algae bioindicator in a similar 
way to the respective solubilized metals. However, these researchers noted the 
metals accumulated in different regions of the cells, and the nanoparticles were 
retained mainly in the cell wall, while the metals were observed mainly in the 
organelles, as fragments of the endoplasmic reticulum. However, in both ways, the 
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authors point out that the accumulated metal could be transferred by the trophic 
chain and carried to other organisms.
When a nanomaterial enters a living organism, several components can adhere 
to its surface, drastically modifying its interaction with cellular structures. Proteins 
are molecules that can adhere to the nanomaterial and form a type of coating, called 
biomolecular corona [27]. This corona may alter the ability of a nanomaterial to 
cross physiological barriers, influencing its toxic potential [7].
According to Drasler et al. [22], in vitro assays performed with cell culture can 
indicate the biological fate of nanomaterials at the cellular and multicellular level, 
even in an excluding mode according to the cell type (i.e., to determine which cell 
type is actually affected by a certain type of nanomaterial).
5. Methods for evaluating the toxicity of nanomaterials
Within nanotoxicology there is an impasse on how best to assess the possible 
adverse effects of nanomaterials, both for human health and environmental 
monitoring. Toxicity tests may be performed employing live (in vivo) organisms, 
such as microcrustaceans, fishes, rodents, and other animals and/or cell cultures (in 
vitro). Several standardized toxicological tests are available to measure the biologi-
cal response of an organism to a chemical. However, there is no standardization for 
the evaluation of the toxicity of nanomaterials, which hampers the comparison of 
results and the consensus about their toxicity. Most of the studies performed so far 
are adaptations of the standard procedures used for other substances [3]. Although 
some minimal combinations of assays have been proposed, Drasler et al. [22] have 
described that there is no standard evaluation protocol due to the wide range of 
physicochemical properties that nanomaterials can present.
Animal tests are more predictive for human effects but have limitations, mainly 
because of physiological and biochemical differences between the species. In 
addition, there is a growing public and legal demand that ethically supports the 
substitution of animal testing for alternatives not based on in vivo testing. New 
concepts of experimentation have been based on strategies with primary culture of 
human cells and permanent cultures of well-established cell lines, since they pres-
ent efficient, cheap, and reliable results [22].
Understanding the demand for orientation and applicability, this chapter will 
address some of the main evaluation methods, developed both in vivo and in vitro, 
to better characterize the toxicity of nanomaterials.
5.1 In vivo methods
In vitro evaluations have increased considerably, but in vivo validation still is 
necessary to understand and interpret its results. Furthermore, animal experi-
mentation was also part of the NanoTEST project, whose purpose was to under-
stand the effects on the physiology of organisms tested. Currently, the OECD 
presents some test guidelines on which biomarkers should be used for each test 
organism [10].
In general, there are more researches on human toxicity, using rodent models, 
whereas few in vivo studies addressing the ecotoxicity of nanomaterials are avail-
able. Furthermore, most of those found in the literature consider the impact of 
nanomaterials on aquatic organisms, since the continental and marine waters end 
up being the main receiving compartment. Some scarce trials address the toxicity 
of nanomaterials in soil and in atmosphere, commonly as suspended particles. In 
general, bacteria (e.g., Aliivibrio fischeri), algae (e.g., Raphidocelis subcapitata), 
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nematodes (e.g., Caenorhabditis elegans), microcrustaceans (e.g., Daphnia magna, 
D. pulex, Ceriodaphnia dubia), mollusks (e.g., Lymnaea stagnalis), fish (e.g., Danio 
rerio), and rodents (Wistar rat and mice) are the most used test organisms for the 
evaluation of acute toxicity (Table 2).
5.2 In vitro methods
According to Drasler et al. [22], assays can be performed with primary cultures 
or eternal cell lines. According to these authors, cell lines are preferably chosen 
because they present great homogeneity and stability, which favors reliability in 
the results, especially in initial tests. For more specific tests, these same researchers 
recommend the use of 3D co-cultures, to better understand the mechanisms of 
action of nanomaterials on tissues.
For the nanomaterial toxicity evaluation, the use of epithelial cell lines (skin, 
gastrointestinal tract, or lung) is usually indicated as these cells present charac-
teristics of real barriers against harmful agents and are therefore the first to suffer 
the influence of these compounds [37]. However, it is important to note that some 
strains may not be responsive to the effects of nanomaterials and, in this case, 
primary cultures may be more indicated [22].
Aiming at the reproducibility of in vitro assays with culture of cell lines, it is 
necessary to record details that are generally missing from the publications. The ori-
gin of the cells, the number of the passage, the detailed method of cell culture, the 
brand of plastics, and reagents used during the cultivation/exposure, besides the 
description of the morphology, growth, and cell differentiation, before and after 
the test, are the information that should be included in the results’ publication [22]. 
Among the in vitro assays, those performed with mammalian cells are considered to 
be more important than those performed with other cell types [13].
For the in vitro comet assay with mammalian cell culture, Collins et al. [23] 
make some recommendations: (1) use non-cytotoxic concentrations (less than 
20% of cell viability loss; if the nanomaterial is not cytotoxic, concentrations 
below 100–150 μg/mL are recommended); (2) choose the cell type according to 
the exposure scenario (based on exposure route and target organ); (3) determine 
both short (2–3 h) and long (24 h) tests to obtain a better understanding of the 
mode of action of the nanomaterial; and (4) determine if the genotoxic damage 
evidenced is a result of the direct effect with the DNA or due to the oxidation of the 
DNA. According to Drasler et al. [22], the exposure period is one of the main factors 
related to contradictory toxicity results for identical nanomaterials, as this involves 
transformations and the aging of their components.
In vitro assays can cover specific endpoints, such as dermal absorption, skin and 
eye irritation, endocrine disruption, and genotoxicity, among others. Among the 
tests, most nanomaterial evaluation protocols align the main routes of exposure, 
being dermal, oral, and inhalation [22].
According to Catalán et al. [13], the relevance and limitations of genotoxicity/
mutagenicity assays should be taken into account when choosing the most appro-
priate monitoring method. According to these authors, the tests considered in the 
evaluation should be based on three categories, following the importance order: 
(1) gene mutation, (2) chromosomal damage, and (3) DNA damage. DNA damage 
is considered a mild effect because of the possibility of repair, while chromosomal 
damage and gene mutation are considered to be severe effects because they are 
irreparable changes.
Regarding the mutagenic potential of nanomaterials to humans, the effects 
observed in vivo should be considered more relevant than those observed in vitro, 
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Nanomaterial Mean 
diameter 
of the 
particles 
(nm)
Test organism Main results References
Ag 13–17 nm Lymnaea stagnalis 
(Mollusca)
Growth 
alteration and 
bioaccumulation
Croteau et al. 
[28]
ZnO
TiO2
15–30 nm Skeletonema 
marinoi (Diatom—
Skeletomataceae), 
Thalassiosira 
pseudonana (Diatom—
Thalassiosiraceae), 
Dunaliella 
tertiolecta (Algae—
Dunaliellaceae), 
Isochrysis galbana 
(Algae—
Isochrysidaceae)
Only nanoparticles 
of ZnO have 
decreased growth 
rate of diatom and 
algae population
Miller et al. [29]
Graphene 
family 
nanoparticles
— Caenorhabditis elegans 
(Nematoda)
Decreased 
reproduction rates
Chatterjee et al. 
[30]
ZnO
CuO
AgO
ZnO: 
20–30 nm
CuO: 
20–100 nm
AgO: 
20–70 nm
Thalassiosira 
weissflogii (Diatom—
Thalassiosiraceae)
Decreased diatom 
population growth 
in similar way 
to respective 
dissolved metals. 
Bioaccumulation of 
nanoparticles in cell 
wall and possible 
transfer through 
trophic chain
Bielmeyer-
Fraser et al. [26]
ZnO
Al2O3
TiO2
— Danio rerio (Chordata) Metal oxide 
nanoparticles 
induced different 
toxic effects 
in zebrafish 
development 
according to each 
metal. ZnO delayed 
larvae and embryo 
development and 
also induced serious 
ulceration in larvae
Zhu et al. [31]
TiO2 ~43 nm Pimephales promelas 
(Chordata)
Fish 
immunotoxicity 
and gene expression 
alteration
Jovanović et al. 
[32]
TiO2 5, 10, and 
32 nm
Xenopus laevis 
(Chordata)
Significantly 
affected tadpole 
growth. The highest 
concentration 
caused mortality, 
suppressed tadpole 
body length, and 
delayed animal 
development
Zhang et al. [33]
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Nanomaterial Mean 
diameter 
of the 
particles 
(nm)
Test organism Main results References
TiO2 — Daphnia similis 
(Crustacea)
The highest 
concentration 
(100 mg L−1) did 
not induce toxic 
effects under 
experimental 
conditions. A 
mixture of TiO2 
forms induced 
toxic effects by ROS 
generation when 
exposed to UVA 
light
Marcone et al. 
[34]
TiO2
ZnO
CuO
TiO2: 
25–70 nm
ZnO: 
50–70 nm
CuO: 30 nm
Vibrio fischeri 
(Gammaproteobacteria), 
Daphnia magna 
(Crustacea), 
Thamnocephalus 
platyurus (Crustacea)
Suspensions of 
nano- and bulk 
TiO2 were not 
toxic. A nano-ZnO 
formulation was 
very toxic to V. 
fischeri, D. magna, 
and T. platyurus. 
Cu compound 
also showed 
toxicity; however, 
for Daphnia 
magna were less 
bioavailable than 
for bacteria
Heinlaan et al. 
[35]
Metallic 
nanoparticles 
of Ag, Cu, Al, 
Co, Ni and 
TiO2
Ag (20–
30 nm), Cu 
(15–
45 nm), Al 
(51 nm), Co 
(10–
20 nm), Ni 
(5–20 nm), 
and TiO2 
(30 nm)
Raphidocelis 
subcapitata (Algae—
Selenastraceae), 
Ceriodaphnia dubia 
(Crustacea), Daphnia 
pulex (Crustacea), 
Danio rerio (Chordata)
Nanometals caused 
acute toxicity in 
multiple aquatic 
organisms, but 
the effect was 
different according 
to the metal particle 
and the species 
used. Since R. 
subcapitata, C. 
dubia, and D. pulex 
were susceptible 
to nanometals, 
trophic chain could 
be compromised
Griffitt et al. 
[19]
Ag
ZnO
TiO2
CeO2
Cu
Ag (15 nm)
ZnO 
(34–42 nm)
TiO2 
(10–23 nm)
CeO2 
(10–33 nm)
Cu (76 nm)
Raphidocelis 
subcapitata (Algae—
Selenastraceae), 
Daphnia magna 
(Crustacea), Danio rerio 
(Chordata)
Ag and Cu 
nanoparticles 
affected all 
organisms; ZnO 
was toxic to algae 
and daphnids; TiO2 
and CeO2 were 
toxic only to algae
Hund-Rinke 
et al. [36]
Table 2. 
Experimental conditions and obtained results through in vivo tests.
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since the first allow the detection of inflammation and, therefore, secondary 
genotoxic effects [13]. Although more predictive for human effects, animal tests 
still have limitations, mainly because of the physiological and biochemical differ-
ences between species. Also, there is a trend to substitute animal testing for suitable 
alternatives that do not promote pain and suffering [22].
Among the tests recognized by the scientific community, those with certified 
guidelines for nanomaterial assessment have greater “weight” than others that 
have not been validated in the determination of genotoxicity/mutagenicity [13]. 
Although they cannot be used to determine mutagenicity, the remaining assays can 
be used to demonstrate the genotoxic potential of nanomaterials.
There are several recommended tests to assess nanomaterials, especially those 
described by the OECD. In accordance with the OECD guidelines [38], in order to 
select a test and evaluate the genotoxicity of a nanoform, exposure, absorption, 
solubility, metabolites, and other derivatives should be considered, as well as pos-
sible side effects (e.g., generation of ROS).
Comparing the genotoxicity tests for chemical substances, the comet assay and 
the micronucleus test are also the most indicated and used by the researchers [13]. 
The comet assay (single cell gel electrophoresis) is a common method of DNA 
damage evaluation, which can be performed with very diverse cell types. Briefly, 
a suspension of individualized cells is mixed with agarose and placed on a prege-
latinized slide. Then, cell lysis on Triton X-100 removes membranes and soluble 
cellular components, while NaCl removes the histones from the DNA, promoting a 
superadhesion of this material to a matrix, forming a structure known as a nucleoid. 
When there are breaks in DNA strands (single or double), the fragments tend to 
move toward the anode during electrophoresis. When there is damage and it is 
observed by fluorescence microscopy, a comet-like image is noted. The percentage 
of DNA in the tail is proportional to the frequency of breaks, that is, the damage 
inferred to the genetic material [23].
As described by Collins et al. [23], several nanomaterials (e.g., TiO2, ZnO, 
Au, Ag, Co3O4, Fe3O4, SiO2, ZrO2, and others) have already been evaluated by 
variations of the comet assay with specific endonucleases for some lesions, 
which increase the power of this tool. Among these enzymes, formamidopy-
rimidine DNA glycosylase (FPG) recognizes lesions of the 8-oxo-7,8-dihy-
droguanine (8-oxoG) and formamidopyrimidine type (open-ring purines) 
and is therefore widely used to estimate oxidative damages to DNA caused by 
 nanomaterials [23].
However, other famous trials are not recommended, such as the Ames test [13]. 
Catalán et al. [13] discourage the use of this test to evaluate nanomaterials, since 
some compounds are unable to cross the bacterial wall, while others have bacteri-
cidal effect.
6. Final considerations
Undoubtedly, nanoscience and nanotechnology offer the prospect of great 
advances to the most different sectors of industry and medicine. However, as any 
area of technology that makes intensive use of new materials/structures, it brings 
some risks to the health of organisms and the environment. Generally, toxicologi-
cal studies involving nanomaterials are still scarce, with results often controversial 
when compared to each other, mainly due to incipient standardization. In this 
context, the combination of in vitro and in vivo methods in a battery of tests is still 
the best way to assess the toxicity of nanomaterials [22, 23].
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One of the major concerns is the choice of dose/concentration range of nano-
materials to be tested. The inclusion of excessively high doses/concentrations may 
generate false positives, while excessively low doses may prevent detection or may 
underestimate the genotoxic potential [23]. Drasler et al. [22] provide all guidelines 
to be considered in evaluating the toxicity of nanomaterials by cell culture, but 
in vivo evaluation must not be overlooked. Paschoalino et al. [3] state that the 
environmental risk analysis of nanomaterials depends mainly on the regulatory 
structure, which involves the generation of protocols, which must be based on a 
multidisciplinary interaction, in order to obtain a more risk assessment possible.
As demonstrated by Valsami-Jones and Lynch [18], harmonization of methods 
and approaches could benefit this young science, as there is still no consensus 
on basic assessment protocols. Current protocols involve specific techniques and 
methods to collect and analyze data sufficient to quantitatively describe the release, 
destination, transport, transformation, exposure, and toxicity of chemicals. 
Furthermore, in order to be more precise about the toxicity and mechanism of 
action of nanomaterials on living organisms, the physicochemical characteristics 
must be sufficiently detailed. So far, a great effort has been made by the OECD to 
try to standardize test methods that can correctly evidence the risk of nanomateri-
als. There are a number of internationally accepted test guidelines that are used for 
toxicity assessment involving trials with organisms for aquatic, soil, and sediment 
monitoring. Since 2013, experts from all over the world hold strategic meetings 
to determine what directions the OECD should take regarding the assessment of 
nanomaterials, as explored in the Petersen et al. [39].
Also, there is a lot of potential in computational models to help elucidate the 
possible effects of nanomaterials on humans and the environment. Currently, 
the quantitative structure-activity relationship (QSAR) model seems to be quite 
adequate because it can relate the structural, physical, and chemical characteristics 
to the behavior that some nanomaterial can present. To date, the combination of 
field, laboratory, and computational work still is the most promising technique to 
ensure reliable responses to the issues involved with nanomaterial toxicity.
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